Client
UCB Farchim S.A.
Architect
Itten+Brechbühl AG
Planning
2011-2012
Start of construction
2012
Start-up of operations
2014
Floor space
24 450 m2
Workplaces
130
Photos
Vincent Jendly, Lausanne
Back
Bulle, Switzerland
UCB Bioreactor
| Client | UCB Farchim S.A. | ||||||
| Planning / Construction | 2011-2012 | ||||||
| Services provided by IB |
|
||||||
| Architecture | Itten+Brechbühl AG | ||||||
| Surface area | 24'450 m2 | ||||||
| |||||||
For the production of its drug Cimzia, UCB has built a new production facility with three bioreactors in Bulle, Freiburg, which is one of the most modern plants for biotech drugs in the world.
The reflective shell of the building alleviates the effect of planting such a straight-lined structure in an Alpine setting. The mathematical language of the façade shows the various functions of the building. The interior design is an open network which creates a clear structure. Maximum use is made of the available space.
The usages are complex: three reactors for which 33 kilometres of pipelines were laid, cleaning and storage tanks, labs for quality assurance, maintenance and storage space as well as offices.
